Discover the detailed record of transactions filed by Febbo Phillip G., Chief Scientific & Med Officer. Insider active across 2 companies, notably Veracyte, INC.. In total, 9 filings have been published. Total volume traded: €741k. The latest transaction was filed on 6 October 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Phillip G. Febbo is the Chief Scientific and Medical Officer at VERACYTE, INC. and ILLUMINA, INC. He oversees the scientific and medical initiatives of the companies, contributing to innovation in the biotechnology field. His expertise is essential for developing new solutions.